Related Articles
CHANGES IN PLASMA IRON LEVELS FOLLOWING CARBOPLATIN ADMINISTRATION
Survey of chemotherapy‑induced nausea and vomiting in patients with urothelial carcinoma
PHARMACOKINETICS OF CARBOPLATIN IN A PATIENT WITH BOTH TESTICULAR CANCER AND HEMODIALYSIS-REQUIRING KIDNEY FAILURE
Phase I study of carboplatin, cisplatin, and cyclophosphamide without and with lenograstim for the treatment of ovarian cancer
[Corrigendum] Survival outcomes in patients with T3‑4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy